Condensed Consolidated Statements of Operations - Bird Rides [Member] - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2021 |
Sep. 30, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
|
| Revenues: | ||||
| Revenue | $ 65,406 | $ 40,185 | $ 151,120 | $ 70,683 |
| Depreciation on revenue earning vehicles | 17,253 | 7,904 | 33,811 | 18,033 |
| Gross margin | 13,463 | 1,081 | 31,242 | (21,668) |
| Other operating expenses: | ||||
| General and administrative | 30,837 | 35,381 | 92,792 | 120,175 |
| Selling and marketing | 3,392 | 4,283 | 10,880 | 13,633 |
| Research and development | 5,804 | 6,157 | 19,096 | 28,265 |
| Tariff reimbursement | (24,637) | |||
| Total operating expenses | 40,033 | 45,821 | 122,768 | 137,436 |
| Loss from operations | (26,570) | (44,740) | (91,526) | (159,104) |
| Interest expense, net | (325) | (1,515) | (5,011) | (5,006) |
| Other (expense) income, net | (9,993) | 2,520 | (60,107) | 163 |
| Loss before income taxes | (36,888) | (43,735) | (156,644) | (163,947) |
| (Benefit from) provision for income taxes | (20) | 60 | 110 | 147 |
| Net loss | (36,868) | (43,795) | (156,754) | (164,094) |
| Adjustment to net loss attributable to common stockholders | (4,940) | (13,298) | ||
| Net loss attributable to common stockholders | $ (41,808) | $ (43,795) | $ (170,052) | $ (164,094) |
| Net loss per share attributable to common stockholders, basic and diluted | $ (0.72) | $ (0.98) | $ (3.04) | $ (4.09) |
| Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted | 58,156,529 | 44,660,774 | 55,865,840 | 40,117,503 |
| Sharing [Member] | ||||
| Revenues: | ||||
| Revenue | $ 64,027 | $ 33,579 | $ 142,314 | $ 59,320 |
| Cost | 33,312 | 24,517 | 77,041 | 55,378 |
| Product Sales [Member] | ||||
| Revenues: | ||||
| Revenue | 1,379 | 6,606 | 8,806 | 11,363 |
| Cost | $ 1,378 | $ 6,683 | $ 9,026 | $ 18,940 |
| X | ||||||||||
- Definition Tariff reimbursement. No definition available.
|
| X | ||||||||||
- Definition Cost of product sold and service rendered, excluding depreciation, depletion, and amortization. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net amount of operating interest income (expense). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|